Gemcitabine induced cardiomyopathy: a case of multiple hit cardiotoxicity
MetadataShow full item record
CitationMohebali, Donya, Jason Matos, and James Ducksoon Chang. 2016. “Gemcitabine induced cardiomyopathy: a case of multiple hit cardiotoxicity.” Esc Heart Failure 4 (1): 71-74. doi:10.1002/ehf2.12113. http://dx.doi.org/10.1002/ehf2.12113.
AbstractAbstract Gemcitabine is a commonly used antineoplastic agent used to treat a variety of cancers with rarely reported cardiac side effects. We describe a case of a 67‐year‐old woman with follicular lymphoma who experienced a rarely reported side effect of gemcitabine: cardiomyopathy. This case highlights a multiple hit mechanism of myocyte damage that may occur following the use of multiple cardio‐toxic agents despite their administration in doses not associated with cardiotoxicity.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:31731630
- HMS Scholarly Articles